Med-Info. Introduction to Korean medical device regulations. TÜV SÜD Product Service GmbH
|
|
- Sylvia Ryan
- 6 years ago
- Views:
Transcription
1 Med-Info International expert information for the medical device industry Introduction to Korean medical device regulations The Ministry of Food and Drug Safety (MFDS) is the healthcare agency having overall responsibility for in Korea. Structure of Korean legislation Medical Devices Act (MDA) Enforcement Decree of MDA Enforcement Regulations of MDA framework of major regulatory programs and basis for GMP requirements in Annexes MFDS notifications of MDA most detailed regulations for technical requirements, review standards, and processes* MFDS standards and guidelines guidelines for industry and MFDS assessors MFDS notifications related to Under the legislations, most detailed regulations for technical requirements, review standards, and processes are regulated as MFDS notifications. Some important notifications for device registration process are: Regulation on approval, notification, and assessment of Standards for manufacture and quality management of (GMP) Regulations for product classification of Re-evaluation (re-examination) of MFDS standards and guidelines related to MFDS standards are published upon demands from the industry and assessors, referring to widely recognized international standards, e.g. IEC and ISO standards, but considering national deviations. The standards are: Horizontal standards for electrical safety, biological safety, electro-compatibility and safety testing requirements Vertical standards for respective product categories Guidelines as nonbinding documents are published for industry and MFDS assessors. Examples are: Guideline on medical device evaluation Guidelines on technical document review Guideline on labeling for Guideline on GMP audit Guideline on GMP audit for foreign manufacturers of imported products * The regulations with most current versions are to be checked via the MFDS website ( The laws and notifications are partly available in English, but not always as latest versions. TÜV SÜD Product Service GmbH
2 Classification of (MD) and responsible organizations Class* Criteria Product assessment** Product approval GMP audit TDR SER IV high risk III II I medium serious potential risk low potential risk little potential risk MFDS MFDS MFDS, Head Office Third-party TF MFDS MDITAC*** reviewer MDITAC*** Third-party GMP inspector + MFDS officer n/a * The classification of each medical device is listed in a MFDS notification. ** A technical document review is a general technical file review (TDR) for those products that are basically the same as an already approved product, whereas a safety and efficacy review (SER) is required for devices unlike those currently available on the market falling under new structure, new performance, new intended use, and newly developed. *** Medical Device Information & Technology Assistance Center Importer To access the Korean medical device market, the importer based in Korea is to be designated for foreign manufacturers, and has to be: a business license holder for medical device import, possibly a subsidiary of a foreign manufacturer, an independent distributor, local manufacturer or other legal entity, an applicant for product registration process and responsible for postmarket surveillance. Premarket requirements For marketing, the following requirements are to be fulfilled: Product license Quality system regulation KGMP audit and approval Product license All require a premarket registration from MFDS before importing and putting on the market. There are two types of premarket product licenses: Premarket notification for Class I devices Premarket approval for Class II, III and IV devices
3 Premarket registration Class I Class II, III, IV Notification Approval product notification general technical document review safety and efficacy review Technical documents Technical documents Test reports Test reports Clinical study reports Premarket notification for Class I devices Premarket notification requires only a documentary review of product information. Manufactures or importers Auto-registration by the online submission A certificate of notification will be available online MFDS systems (an electronical window for civil petitions to MFDS) MFDS does not accept: Submission for a medical device requiring the approval process Submission for a nonmedical device Premarket approval for Class II, III and IV devices For Class II the application must be submitted to MDITAC for product approval, after complete technical document review by third-party reviewers. TÜV SÜD Korea is a third-party reviewer organization for technical document review for all product categories of Class II. For Class III and IV the application has to be submitted to MFDS, Head Office, for product approval after technical document review by MFDS.
4 review of technical documents Notification of conformity from technical document review certificate of product approval Certificate of product approval In case of Class III and IV devices the applications for technical document review and for product approval can be submitted together. The application for certificate of product approval is a formal process by MFDS without any further technical review. Technical document review A technical document review is a general technical document review (TDR) for those products that are basically the same as an already approved product, whereas a safety and efficacy review (SER) is required for devices unlike those currently available on the market falling under new structure, new performance, new intended use, and newly developed. Technical documents for all Class II are reviewed by third parties, whereas Class III and IV are reviewed by MFDS. General technical document review (TDR) Devices substantially equivalent as previously approved products Clinical study reports are not required Safety and efficacy review (SER) Required for devices with new-to-market features new developments, new performance, new structure, and/or new intended use Significant difference affecting safety and effectiveness Clinical study reports are essential, in addition to TDR requirements Technical document file contains Intended use (IFU) Physical, chemical characteristics Biological safety Electromagnetic compatibility Stability report (including shelf-life test) Principle of operation Electrical, mechanical safety Irradiation safety Function In addition to TDR, SER requires: Original developer Clinical investigation data Design history and background Market history in foreign countries In the product registration procedure, the Class II medical devices defined as equivalency-notified products are exempt from the technical document review process, and those defined as modified products are partially exempt. What is a equivalency-notified product? Medical devices, which are equivalent to premarketed devices for the intended use, operation principle or used materials (for nonactive ), performance, test specification and operation method, etc. Additional information has to be given for the device under review Equivalency-notified and regularly updated by MFDS Test report required to identify the equivalency issued by MFDS-registered test laboratories Medical device testing The test reports issued by the following laboratories are recognized to support the function, safety and effectiveness MFDS-registered laboratories IEC-registered laboratories (CBTL) KOLAS-accredited laboratories (Korea Laboratory Accreditation Scheme acc. to ISO 17025) GLP laboratories accredited according to OECD rules TÜV SÜD can provide IEC reports and GLP reports for MFDS registration. Clinical trials Required for SER products MFDS approval required for protocol and clinical trial studies Clinical investigation by medical device clinical trial centers qualified by MFDS (GCP)
5 The clinical studies performed in foreign countries are recognized only if: Compliance to GCP and ISO The study reports have been accepted by the healthcompetent authority of OECD member countries in the product registration process. Quality system regulations (KGMP) All are required to be manufactured under GMP. Premarket GMP audit is mandatory for all Class II, III and IV devices and Class I (sterile and measuring devices). Certification of compliance to Standards for manufacturing and quality management of medical devices (KGMP, similar to ISO 13485) Both, document review and site inspection conducted by third-party GMP inspector organization, the audit team accompanied by MFDS officer Update every 3 years Currently, a MFDS guideline was published on GMP audit for foreign manufacturers of imported products and implemented with the time frame: Class IV: from April 8, 2012 Class III: from 2013 Class II from 2014 In case of many manufacturing sites per importer, the manufacturing sites will be sampled depending on the criteria of product risk, importing volume, PMS data, etc. The following issues are not focused during TDR/SER processes but during the GMP audit: Sterilization process validation Risk management file Postmarket surveillance The product license holder (local manufacturer and importer) has legal responsibility for the product marketing process and postmarket surveillance activities: Patient record control required for designated products for medical device tracking such as cardiac implant devices, breast implants, implantable infusion devices, defibrillator and continuous ventilator Adverse event/safety alert reporting for adverse effect, new safety information from PMCF and/or literature Recalls in case of effects on safety, effectiveness or quality defects Re-evaluation and re-examination Our service for medical device registration Technical document review service for all Class II as third-party reviewer, registered to MFDS CB report issuance for electrical/electronic GLP report issuance for biocompatibility of body-contact Pretechnical meeting to identify the gaps for MFDS approval KGMP mock inspection service Your contact partner at TÜV SÜD Product Service can provide further information. Foreign Affairs Phone: MHS-FA@tuev-sued.de TÜV SÜD Korea Phone: mhs_enquiry@tuv-sud.kr TÜV SÜD Product Service GmbH, Medical and Health Services, Ridlerstr. 65, Munich TÜV SÜD Korea Ltd. 29F, Two IFC, 10, Gukjegeumyung-ro, Yeongdeungpo-gu, Seoul, 07326, Republic of Korea (South Korea) TÜV SÜD Product Service GmbH I PS-MKG/MHS/medinfo/10.2/en/DE
Korean Medical Devices Regulations
Korean Devices Regulations The Ministry of Health and Welfare (MHW) is the healthcare agency having overall responsibility for Devices. The Korea Food and Drug Administration (MFDS), an agency under MHW,
More informationTuesday, 21 October Jang Yong Choi
Tuesday, 21 October 2014 Jang Yong Choi Contents Status of Medical Device Industry in Korea MFDS Organization and Responsibilities Medical Device Regulation Overview Medical Device Regulation Updates I.
More informationYour Vision, Our Future Korean Medical Device Your Vision, Our Future
www.mfds.go.kr/eng Your Vision, Our Future Korean Korean Your Vision, Our Future 01 Passion for Growth & Excellence With a 5% average annual growth rate, the Korean medical device market was valued at
More informationData Collection Tools Functions, Indicators & Sub-Indicators
Data Collection Tools 27- Functions, Indicators & A. National regulatory system Indicator RS1: Legal framework for establishment of a regulatory system, mandate and enforcement power for each function
More informationKorea GMP & DMF. April Korea Pharmaceutical Traders Association Deputy director Oh Hyun, Kwon
Korea GMP & DMF April. 2015 Korea Pharmaceutical Traders Association Deputy director Oh Hyun, Kwon Contents 1. KPTA 2. Pharmaceutical industry 3. KGMP 4. KDMF KPTA KPTA Purpose ㅇ Trade promotion of pharmaceuticals,
More informationRegulatory Framework in Japan - Past and Future - Building a Regulatory Framework Essential Elements of Compliance / Surveillance
Regulatory Framework in Japan - Past and Future - Building a Regulatory Framework Essential Elements of Compliance / Surveillance Nobuo UEMURA Director Office of Medical Devices III Pharmaceuticals and
More informationFDA Requirements for Clinical Investigations of Medical Devices: A Review for European Manufacturers
FDA Requirements for Clinical Investigations of Medical Devices: A Review for European Manufacturers Autumn Dawn Ediger, 1, * Birgit Limbach 2 and Dieter Dannhorn 3 1 Regulatory Affairs, Clinical QM and
More informationQUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION
PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/W 1/2011 2 Annexes 22 July 2011 QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PIC/S 2011 Reproduction
More informationKFDA Regulatory Framework on Biopharmaceuticals - Focus on Biosimilar
KFDA Regulatory Framework on Biopharmaceuticals - Focus on Biosimilar Kyung-Min Baek, Ph.D. Recombinant Protein Products Division Korea Food and Drug Administration(KFDA) Biopharmaceuticals A biopharmaceutical
More informationIn the huge expanse of Asia, Singapore and
New Medical Device Regulation 16 February 2009 By Ames Gross In the huge expanse of Asia, Singapore and Hong Kong are small places. However, after Japan, they are among the most advanced medical markets
More informationPost market Surveillance ISO EU Medical Device Regulation
Post market Surveillance ISO13485 2016 EU Medical Device Regulation Patrick Caines, Ph.D. Baxter Healthcare 15 June 2017 Agenda Post market Regulatory Requirements ISO 13485 2016 Summary of key changes
More informationTHE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES
THE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES Agnette de Perio Peralta and Maria Cecilia Credo Matienzo (apperalta@co.doh.gov.ph and mccmatienzo@yahoo.com) Center for Device
More informationRegulation of vaccines: building on existing drug regulatory authorities
WHO/V&B/99.10 ORIGINAL: ENGLISH DISTR.: GENERAL Regulation of vaccines: building on existing drug regulatory authorities DEPARTMENT OF VACCINES AND OTHER BIOLOGICALS World Health Organization Geneva 1999
More informationNational laws. National Competent Authority / Authorities. Orders, ordinances (supervision)
1 The Regulatory World Only for products classified higher than class I: Notification of the body, Supervision National laws National Competent Authority / Authorities Orders, ordinances (supervision)
More informationQMS (Quality Management System) for Medical Device in Japan
QMS (Quality Management System) for Medical Device in Japan 1 st Korea Japan Symposium 23 June, 2016 Katsuya SAWADAISHI Office of Manufacturing/Quality and Compliance Division of Medical Devices Main Topics
More informationGuide to Scientific and Regulatory Advice for GXP activities
Guide to Scientific and Regulatory Advice for GXP activities ADV-G0019-1 7 OCTOBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.
More informationApproved by Resolution of the Ministry of Health of the Republic of Belarus No. 55 dated April 23, 2015
RESOLUTION of the Ministry of Health of the Republic of Belarus No. 55 dated April 23, 2015 On certain measures on realization of the Resolution of the Council of Ministers of the Republic of Belarus No.
More informationMedidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer
Nano-Tera.ch 05 February 2015 part 8 PMA, 510k, IDE Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 USA/FDA Pre Market Approval System - PMA, Pre Market Notifcation
More informationThe European Medicines Agency Inspections ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA:
The European Medicines Agency Inspections London, 20 September 2007 EMEA/INS/GCP/197221/2005 Procedure no.: INS/GCP/3/IV ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: SPONSOR
More informationTechnical Guidance on Clinical Evaluation of Medical Devices
Annex Technical Guidance on Clinical Evaluation of Medical Devices I. Purpose The clinical evaluation of medical devices is the assessment procedure conducted by registration applicants to validate whether
More informationChanges to the Medical Devices Directive and affect on Manufacturers
TÜV Product Service Ltd Webinar 18 th November 2009 Changes to the Medical Devices Directive and affect on Manufacturers Henry Sibun Manager, Medical & Health Services UK CONTENTS / 1. Introduction 1.
More informationMedical Device Single Audit Program (MDSAP) An Overview Canadian Experience
Medical Device Single Audit Program (MDSAP) An Overview Canadian Experience Linda Chatwin Sr. Customer Solutions Consultant : 360-817-5556 : linda.chatwin@ul.com LINDA M CHATWIN, Esq, RAC Biography Ms.
More informationJournal home page: RESEARCH ARTICLE
Journal home page: http://www.journalijiar.com INTERNATIONAL JOURNAL OF INNOVATIVE AND APPLIED RESEARCH RESEARCH ARTICLE QUALITY AUDIT AND GMP INSPECTION OF PHARMACEUTICAL INDUSTRY WITH REFERENCE TO USFDA;
More informationBaek, Kyung-min. Recombinant Protein Products Division. Ministry of Food and Drug Safety
Baek, Kyung-min Recombinant Protein Products Division Ministry of Food and Drug Safety About Ministry of Food and Drug Safety Regulation for Biosimilar Principle of Biosimilar Approach Status of Biosimilar
More informationISPE Annual Meeting 29 October 1 November 2017 San Diego, CA
Ministry of Industry and Trade/ Department of pharmaceutical and medical industry development Moscow September 22, 2017 MEDICINES CIRCULATION SYSTEM IN THE RUSSIAN FEDERATION Ministry of Healthcare Medicines
More informationGuideline on Good Pharmacovigilance Practices Module V- Pharmacovigilance System Master File
Guideline on Good Pharmacovigilance Practices Module V- Pharmacovigilance System Master File Turkish Medicines and Medical Devices Agency 16.02.2015 CHAPTER I... 2 1.1. Introduction... 2 CHAPTER II...
More informationTraining manual: licensing, lot release, laboratory access
WHO/V&B/01.16 ORIGINAL: ENGLISH DISTR.: GENERAL Training manual: licensing, lot release, laboratory access DEPARTMENT OF VACCINES AND BIOLOGICALS World Health Organization Geneva 2001 The Department of
More informationMedical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS
Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,
More informationMedical Devices. LATVIA LAWIN Klavins & Slaidins
Medical Devices LATVIA LAWIN Klavins & Slaidins CONTACT INFORMATION Sarmis Spilbergs LAWIN Klavins & Slaidins Elizabetes 15, Riga, LV 1010, Latvia +371 67814848 sarmis.spilbergs@lawin.lv www.lawin.com
More informationInspection of the conduct of clinical evaluations on medical devices in the premises of healthcare providers
ZP-21 Inspection of the conduct of clinical evaluations on medical devices in the premises of healthcare providers This guideline supersedes guideline SÚKL PZT-16 as of November 1, 2004. The purpose of
More informationMEDICAL DEVICES SECTOR
MEDICAL DEVICES SECTOR MDS - G4 GUIDANCE FOR OVERSEAS Version 2 Our mission is to ensure the safety of food. the safety, quality and efficacy of drugs. and the safety and effectiveness of medical devices,
More informationEUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible
More informationMedical Device Registration in China
www.cirs-md.com IVD Medical Device Registration in China Your Local Regulatory Affairs Staff-CIRS CIRS assist you Overseas Medical Devices In Vitro Diagnostic reagent Market access CFDA Registration Pre-market
More informationRE: Docket No. FDA 2017 N 0041: Agency Information Collection Activities; Proposed Collection; Comment Request; Safety Assurance Case
701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationRAC (Canada) Examination Study Checklist
RAC (Canada) Examination Study Checklist Instructions: Use this checklist to track your progress when preparing for the RAC (Canada) certification examination. When you begin your studying, each task statement
More informationKorean Perspective : Recent Trends in the Regulation of Biopharmaceuticals
Korean Perspective : Recent Trends in the Regulation of Biopharmaceuticals Dec. 4, 2017 Heajeong Doh Ministry of Food and Drug Safety, Korea [ Table of Contents] Introduction of MFDS Biopharmaceuticals
More informationCurrent GMP Inspection of PMDA. Shingou SAKURAI, Ph.D Office of Compliance and Standards Pharmaceuticals and Medical Devices Agency(PMDA), JAPAN
Current GMP Inspection of PMDA Shingou SAKURAI, Ph.D Office of Compliance and Standards Pharmaceuticals and Medical Devices Agency(PMDA), JAPAN GMP Inspection related Organizations in Japan Organizations
More informationFocus on : Notified Bodies PMS PMCF. Rob Higgins Head of Regulatory Affairs
Focus on : Notified Bodies PMS PMCF Rob Higgins Head of Regulatory Affairs This session Focus on Notified Bodies Post Market Surveillance Post Market Clinical Follow Up Notified Bodies Included in Commissioner
More information(May 2017) DRAFT FOR COMMENTS
May 2017 Document for comments 1 2 3 4 5 6 7 8 9 10 GUIDANCE ON GOOD PRACTICES FOR DESK ASSESSMENT FOR COMPLIANCE WITH GOOD MANUFACTURING PRACTICES, GOOD LABORATORY PRACTICES AND GOOD CLINICAL PRACTICES
More informationRE: FDA-2011-N-0090: Food and Drug Administration; Unique Device Identification System
November 7, 2012 Margaret Hamburg Commissioner Food and Drug Administration Department of Health and Human Services Room 2217 White Oak Building One 10903 New Hampshire Avenue Silver Spring, MD 20993 RE:
More information5 Countries. 1 Unified Audit.
5 Countries. 1 Unified Audit. UNDERSTANDING THE MEDICAL DEVICE SINGLE AUDIT PROGRAM (MDSAP) Melodie Kahl, Mike Wolf, and Scott Edwards July 2017 For more information, please contact: USA Office: + 1 877
More informationBiosimilar regulation in Republic of Korea and Asia-Pacific Economic Cooperation (APEC) developments
Biosimilar regulation in Republic of Korea and Asia-Pacific Economic Cooperation (APEC) developments Ministry of Food and Drug Safety Jeewon Joung Outline I. Korean Regulatory Framework for Biosimilar
More informationMedical Device Regulatory Framework
Medical Device Regulatory Framework 24 July 2015 SAMED Member Meeting Contents 1. Context 2. Regulatory framework Key concepts Process 3. Changes 4. What to do? 1. Context Act 101 of 1965 as amended Draft
More informationTechnical Guidance on Clinical Evaluation of Medical Devices 1
Technical Guidance on Clinical Evaluation of Medical Devices 1 I. Purpose The clinical evaluation of medical devices is the assessment procedure conducted by registration applicants to validate whether
More informationEuropean Packaging Regulations What to expect from a notified body audit of your packaging
What to expect from a notified body audit of your packaging Dr. Ralf Walther TÜV Süd Product Service GmbH March 3-5, 2009 www.healthpack.net Content 1. Short introduction of TÜV Süd Product Service 2.
More informationA REVIEW OF MARKET ENTRY REQUIREMENTS FOR RISK MANAGEMENT, WITH SPECIAL EMPHASIS ON FDA AND ISO COMPLIANCE
BYLINED ARTICLE ON: A REVIEW OF MARKET ENTRY REQUIREMENTS FOR RISK MANAGEMENT, WITH SPECIAL EMPHASIS ON FDA AND ISO 14971 COMPLIANCE By Mark Leimbeck PE Underwriters Laboratories and Larry Kessler Sc.D.
More informationUnique Device Identification (UDI): What is happening in Korea?
Healthcare Market Access Unique Device Identification (UDI): What is happening in Korea? May 11, 2017 Young Kim Synex Consulting Ltd. Objectives The Ministry of Food & Drug Safety (MFDS) plans to introduce
More informationPharmacovigilance System in Russia and the EAEU
Pharmacovigilance System in Russia and the EAEU Authors: Sergey Simeniv CEO X7 Research, CRO; Olga Latysheva Head of Pharmacovigilance Department X7 Research, CRO; Dmitry Kryuchkov Executive Director X7
More informationGuideline on good pharmacovigilance practices (GVP)
1 2 3 19 June 2012 EMA/119871/2012 4 5 Guideline on good pharmacovigilance practices (GVP) Module III Pharmacovigilance inspections Draft finalised by the Agency in collaboration with Member States and
More informationINFORMATION ON JAPANESE REGULATORY AFFAIRS
2017 INFORMATION ON JAPANESE REGULATORY AFFAIRS Regulatory Information Task Force Japan Pharmaceutical Manufacturers Association Pharmaceutical Administration and Regulations in Japan Japan Pharmaceutical
More informationJanuary 3, AtriCure Inc. Melissa Smallwood Associate Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service January 3, 2017 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 AtriCure
More informationCopyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.
Statutory Framework for Devices Medical Devices Investigational Use Application IDE (21 CFR 812) Abbreviated IDE Exempt Pre-Market Approval Applications 510(k) Pre-marketing Notification (21 CFR 807(e))
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL MEDICAL DEVICES and IVDs ESSENTIAL PRINCIPLES of SAFETY & PERFORMANCE This guideline is intended to provide recommendations to applicants wishing to sell medical devices and IVDs
More informationEXAMPLE OF VENDOR QUALIFICATION FOR IMMUNE EFFECTOR CELL PRODUCT MANUFACTURER
EXAMPLE OF VENDOR QUALIFICATION FOR IMMUNE EFFECTOR CELL PRODUCT MANUFACTURER Disclaimer: This example is just one potential example of a vendor qualification form to verify the adequacy of the internal
More informationReady or Not: The New Medical Device Regulations Are Here!
Ready or Not: The New Medical Device Regulations Are Here! Felicia R Cochran, PhD, CMPP TM feliciacochran@earthlink.net FR Cochran 1 General Disclaimers This presentation represents the knowledge, professional
More informationPOLICY AND PROCEDURE MANUAL
POLICY AND PROCEDURE MANUAL PBRC: POLICY NO. 378.00 ORIGIN DATE: 5/25/2016 IMPACTS: CLINICAL RESEARCH LAST REVISED: 1/1/2017 SUBJECT: SOURCE: PURPOSE PENNINGTON BIOMEDICAL CLINICALTRIALS.GOV POLICY INSTITUTIONAL
More informationISPE Annual Meeting 29 October 1 November 2017 San Diego, CA
Post Marketing Safety Reporting (PMSR) Challenges and Successful Practices for Combination Products Objective Session Goals Summary of the final rule Interpretation for combination products approved as
More informationUNIQUE DEVICE IDENTIFICATION U.S. FDA. March 2014
UNIQUE DEVICE IDENTIFICATION U.S. FDA March 2014 Introduction The Food and Drug Administration (FDA) has released a final rule requiring most medical devices distributed in the United States to carry a
More informationSADCAS POLICY ISO/IEC 17020:2012 TRANSITION
SADCAS POLICY ISO/IEC 17020:2012 TRANSITION Prepared by: SADCAS Approved by: SADCAS CEO Approval Date:2012 09 25 Effective Date: 2012 10 01 Page 1 of 11 Table of Contents Page 1. INTRODUCTION... 3 2. TRANSITION
More informationWhite Paper: Improvements to the Australian Regulatory System for Medical Devices. 23 May 2014
White Paper: Improvements to the Australian Regulatory System for Medical Devices 23 May 2014 mtaa.org.au Medical technology for a healthier Australia 0 www.mtaa.org.au Level 12, 54 Miller St, North Sydney
More informationQualified Persons in the Pharmaceutical Industry. Code of Practice. March 2008
Qualified Persons in the Pharmaceutical Industry Code of Practice March 2008 Updated October 2009 Code of Practice for Qualified Persons 1. INTRODUCTION... 1 2. REGULATORY BASIS FOR THE QUALIFIED PERSON...
More informationConducted Under an IND to Support a
Using Foreign Clinical Trial Data not Conducted Under an IND to Support a US Application PDA Midwest Chapter Meeting March 15, 2018 2013 2017 Regulatory Compliance Associates Inc. All Rights Reserved.
More informationMANAGEMENT SYSTEM CERTIFICATION RULES FOR THE AEROSPACE AND DEFENCE SECTOR RG 02
STATUS OF REVISIONS rev. no. SUMMARY OF AMENDMENTS DATE 1 UNAVIAcert logo update 18/02/2014 0 Reissue for substantial amendments to the document 19/04/2013 AUDIT Quality Director Maria Anzilotta APPROVAL
More informationTopics. Safety First Initiative. Drug Safety Communications DRUG SAFETY INITIATIVES AT THE FOOD AND DRUG ADMINISTRATION
DRUG SAFETY INITIATIVES AT THE FOOD AND DRUG ADMINISTRATION Presentation to the FDA/Industry Conference sponsored by the School of Pharmacy at Temple University May 6, 2008 Topics Safety First initiative
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer
Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.
More informationU.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE
U.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE Jeff Shuren Director Center for Devices and Radiological Health CDRH STRATEGIC PRIORITIES UPDATE The Center for Devices and Radiological Health
More informationMedical Device Directive
Medical Device Directive WG9 - IEC/SC 62A ISO/TC 184/SC 2 Joint Working Group 9 Saeed Zahedi 4 th of July 2012 Blatchford Copyright 2012 Commercial in confidence Definition and Requirements MDD is law,
More informationFINAL DOCUMENT. International Medical Device Regulators Forum. Medical Device Regulatory Audit Reports
FINAL DOCUMENT International Medical Device Regulators Forum Title: Authoring Group: Medical Device Regulatory Audit Reports IMDRF MDSAP Working Group Date: 2 October 2015 Toshiyoshi Tominaga, IMDRF Chair
More informationGood Clinical Practice (GCP): how does a laboratory that supports a clinical trial ensure compliance with these Regulations
Good Clinical Practice (GCP): how does a laboratory that supports a clinical trial ensure compliance with these Regulations 9th edition of Synevo Clinical Research Symposium. 17 th November 2017 Bucharest.
More informationASEAN Pharmaceutical Harmonization Updates. Abida Syed M Haq Ministry of Health, Malaysia
ASEAN Pharmaceutical Harmonization Updates Abida Syed M Haq Ministry of Health, Malaysia Presentation Outline About ASEAN Background Economic Integration Current Status Issues & Challenges Efforts by Malaysia
More informationMaintaining your Investigational Device Exemption (IDE) with the FDA: Keys for Success. Jenna Stump, MS, CCRP Clinical Research Regulatory Specialist
Maintaining your Investigational Device Exemption (IDE) with the FDA: Keys for Success Jenna Stump, MS, CCRP Clinical Research Regulatory Specialist Agenda How an investigator should prepare and submit
More informationGS1 Ireland Healthcare User Group (HUG) Information Day
GS1 Ireland Healthcare User Group (HUG) Information Day Regulatory update Medical Devices and the impact for Irish Healthcare Sinead Duggan, HPRA 28 th March 2017 29/03/2017 2 Medical Devices Regulation
More informationState Control of Medicines and Medical Devices in Russian Federation
Federal Service for Surveillance in Healthcare State Control of Medicines and Medical Devices in Russian Federation Ph.D., Elena Astapenko The Head of the Department of organization of state control and
More informationEA-7/04 Legal Compliance as a part of accredited ISO 14001: 2004 certification
Publication Reference EA-7/04 Legal Compliance as a part of Accredited ISO 14001: 2004 certification PURPOSE The text of this document has been produced by a working group in the European co-operation
More informationGood Manufacturing Practices Purpose and Principles of GMP. Tony Gould
Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines
More informationGENERAL AND ORGANISATIONAL REQUIREMENTS
NBOG working document applicable for MDR and IVDR WD 2017-1 Draft list of documents to be submitted in the application for designation as a notified body under Regulation (EU) 2017/745 and Regulation (EU)
More informationIECEE OPERATIONAL DOCUMENT
IECEE OD-2048 Edition 1.5 2017-05-17 IECEE OPERATIONAL DOCUMENT IEC System of Conformity Assessment Schemes for Electrotechnical Equipment and Components (IECEE System) Utilization of Customers Testing
More informationSECOND SECTION MINISTRY OF HEALTH DECLARATIONS
Tuesday October 26 th, 2010 OFFICIAL JOURNAL (Second Section) SECOND SECTION MINISTRY OF HEALTH AGREEMENT to recognize that the requirements set forth under articles 179 and 180 of the Regulations for
More informationRegulation for Scheme Owners requesting acceptance by ACCREDIA of new Conformity Assessment Schemes and their revisions
Title Reference Regulation for Scheme Owners requesting acceptance by ACCREDIA of new Conformity Assessment Schemes and their revisions RG-19 Revision 00 Date 10-10-2017 NOTE: The present document represents
More informationCGMP Requirements for Investigational Products
PREP #6 CGMP Requirements for Investigational Products Ji-Eun Kim, RPh, PhD Research Pharmacist Regulatory Affairs Office of Research Compliance December 6, 2016 1 CME Disclosure Statement Northwell Health
More informationWork plan for the GMP/GDP Inspectors Working Group for 2017
13 January 2017 EMA/INS/GMP/584202/2016 Work plan for the GMP/GDP Inspectors Working Group for 2017 Chairperson: David Cockburn Adopted: December 2016 1. Meetings scheduled for 2017 Face-to-face meetings
More informationMEDICAL DEVICE. Technical file.
MEDICAL DEVICE Technical file www.icaro-research.eu ICARO MDTF v1.0 1 Mar 2016 1. Do you plan to launch your medical device in Europe? If you re reading this, chances are good that you re considering introducing
More informationTrinity College Dublin QP Forum 2017 Tuesday 25 th April
Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current
More informationISO INTERNATIONAL STANDARD. Implants for surgery Active implantable medical devices Part 4: Implantable infusion pumps
INTERNATIONAL STANDARD ISO 14708-4 First edition 2008-11-15 Implants for surgery Active implantable medical devices Part 4: Implantable infusion pumps Implants chirurgicaux Dispositifs médicaux implantables
More information2. Enterprises qualifying for mandatory audits Non-SMEs.
Guidance Note on the carrying out of mandatory energy audits by non-smes pursuant to LN 196/2014 transposing the energy efficiency Directive 2009/27/EU. 1. Introduction Regulation 10 of LN 196 makes it
More informationGuide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland
Guide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland AUT-G0095-1 15 AUGUST 2014 This guide does not purport to be an interpretation of law and/or regulations and is for
More informationOptimize Your Field Safety Corrective Actions Systems
Optimize Your Field Safety Corrective Actions Systems Patrick Caines, Ph.D. Baxter Healthcare 9 December 2016 1 Agenda International regulatory requirements and expectations for FSCA and recalls Developing
More informationRegulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC
Regulatory Overview of Proposed LDT Framework By Ben Berg, Meaghan Bailey, RAC On July 31, 2014, the U.S. Food and Drug Administration (FDA or the Agency) notified both the Senate Committee on Health,
More informationCorrelation Matrix EN 9100:2016 EN 9100:2009
Correlation Matrix EN 9100:2016 EN 9100:2009 EN 9100:2016 EN 9100:2009 4 Context of the organization 4 Quality management system 4.2 Understanding the organization and its context Understanding the needs
More informationCHAPTER 3 Drug Development
CHAPTER 3 Drug Development 1. PROCESS FROM DEVELOPMENT TO APPROVAL New drugs are defined as drugs with active ingredients, dosage, administration route, or indications, which are clearly different from
More informationKathy Weil Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological Health US Food and Drug Administration
Kathy Weil Division of Bioresearch Monitoring Office of Compliance Center for Devices and Radiological Health US Food and Drug Administration Kathy.Weil@fda.hhs.gov Follow the protocol and IDE regulations
More informationNew Pharmacovigilance legislation. Post-authorisation safety studies. ENCePP Plenary meeting. 3 May 2012
New Pharmacovigilance legislation Post-authorisation safety studies ENCePP Plenary meeting 3 May 2012 Presented by: Annalisa Rubino, PhV and Risk Management, EMA An agency of the European Union Why? Public
More informationUnder this license, you are approved to manufacture aflibercept drug substance intermediate, drug substance, and formulated bulk at
DEPARTMENT OF HEALTH AND HUMAN SERVICES Silver Spring MD 20993 Our STN: BL 125387/0 BLA APPROVAL November 18, 2011 Regeneron Pharmaceuticals, Inc. Attention: Laura Pologe, Ph.D. Associate Director, Regulatory
More informationINTERNATIONAL CONFORMITY CERTIFICATION PROGRAM
KINGDOM OF SAUDI ARABIA INTERNATIONAL CONFORMITY CERTIFICATION PROGRAM COMPREHENSIVE PROCEDURES and GUIDELINES INTERNATIONAL CONFORMITY CERTIFICATION PROGRAM COMPREHENSIVE PROCEDURES AND GUIDELINES November
More informationAudit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd.
Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd. Copyright 2009 - Pharmaceutical Research & Manufacturers Association 1 Overview Audit ICH-GCP,
More informationGCP Convergence Improves Transportability of Medical Device Clinical Data
GCP Convergence Improves Transportability of Medical Device Clinical Data By Harmonization-by-Doing Working Group 4 The safety, performance and effectiveness of medical devices are often evaluated by well-controlled
More informationThe Reply of Egypt to comments submitted by the European Union On notifications G/TBT/N/EGY/114 and G/TBT/N/EGY/115
The Reply of Egypt to comments submitted by the European Union On notifications G/TBT/N/EGY/114 and G/TBT/N/EGY/115 In relation to the European Union s comments on Ministerial Decrees no.43/2016 and no.
More informationUCI Medical Device Regulatory Awareness - Implications for Start-ups - Copyright 2017 Noblitt & Rueland. Contact Information.
UCI Medical Device Regulatory Awareness - Implications for Start-ups - Copyright 2017 Contact Information Mailing Address: 5405 Alton Parkway 5A, #530 Irvine, CA 92604-3718 Phone: (1) 949-398 398-5222
More informationCUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)
21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software
More information